AlloHome
Use
The AlloHome test provides real-time remote transplant surveillance by complementing early detection with AlloSure, using at-home spirometry data to support proactive follow-up. This approach aids in identifying potential lung allograft injury or rejection earlier, allowing for timely intervention and enhancing patient care. With real-time data collection through six customizable devices tailored to the needs of organ transplant patients, the test reduces manual vital sign tracking while supporting automated monthly utilization reports.
Special Instructions
Not provided.
Limitations
The effectiveness of AlloHome depends on consistent and correct use of the devices by patients. The data accuracy might be affected by improper handling or technical malfunctions of the at-home devices. Timeliness and responsiveness to alerts also depend on the patient's and caregiver's engagement.
Methodology
Other
Biomarkers
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided